Aim: To study iron metabolism in patients on programmed hemodialysis (PH) in oral and intravenous administration of iron drugs; to compare clinical and financial results of using such drugs.
Material And Methods: A two-stage trial studied iron metabolism in 158 PH patients on replacement therapy with erythropoetin. They received correction of iron deficiency with oral drugs (stage I) and venofer (stage II).
The efficiency of method worked out by the authors for pulmonary thromboembolism management surpasses the existing routine schemes of treatment by standard doses of streptokinase. The opportune application of this method gives positive results in considerable percentage of cases, i.e.
View Article and Find Full Text PDF